Vascular Biology
Monterey, CA
|
Septmeber 9-12, 2020
Conrad Hotel Seoul
|
|
Partner Network Advantage - New Job Board Feature
|
Why post your job on NAVBO's career center rather than going directly to the larger job networks?
Pricing on the mass job boards can vary, but to get a job noticed you typically have to sponsor it for $5 - $10 per day, which can add up quickly especially since you also pay for each click the job gets. When you add it all together, you could be spending up to $45 per day on your job posting. But, when posting a job on NAVBO's career center, you simply pay a flat fee! The Premium package includes our Exclusive Extended Partner Network - which means the jobs are broadcast to sites like ZipRecruiter and Jobs2Careers and more for a flat fee.
With special member pricing, you can post a job for as low as $300 with this Partner Network. You never pay for each click, just the flat fee on the NAVBO career center. In addition, the Premium package includes a 60-day job posting making it a great value. The Premium packages also offer features like having your company's logo featured on the career center homepage, having your job appear first in search results, and more.
|
Shop at Amazon?
Help Support NAVBO
|
Your data privacy and security are important to NAVBO. To that end, we have updated our privacy policy to reflect recent privacy and security regulation implementations and changes.
Please review our policy as time permits so you have a complete understanding of the data we have, why we have it, and how we use it.
Part of the updates relate directly to the European Union's new General Data Protection Regulation (GDPR) that went into place May 25. The GDPR seeks to improve the transparency of data usage and give end users more control over their own data. We believe these changes are important and will be compliant with the GDPR regulations.
Contact NAVBO if you have any questions or to
change your communication preferences.
Please note, you can unsubscribe to this newsletter at anytime by clicking on the SafeUnsubscribe in the footer.
|
|
 |
|
|
Vascular Biology 2019 - October 27-31 - Monterey, CA
|
Not only is this going to be a very exciting scientific meeting (www.navbo.org/vb2019), but we will be celebrating
NAVBO's 25th Anniversary! Please join us!
Keynote Lecture by Hal Dietz, Johns Hopkins Medical Center:
Leveraging Nature's Success: Lessons from Modifiers of Cardiovascular Disease
Eight concurrent sessions in each workshop:
Boot camp on
Tissue Clarity and Light Sheet Imaging, sponsored by
Miltenyi Biotec and organized by Kristy Red-Horse of Stanford University.
This session requires an additional fee and there is limited space, so register early to secure your seat!
Pre-Conference Meeting for Trainees (Sunday, October 26 at 2:00pm). Features of this four-hour session include presentations by Martin Schwartz, Yale School of Medicine and Jan Kitajewski, University of Illinois at Chicago, a panel discussion with young and upcoming investigators and of course, short talks by graduate students and postdocs.
This session has an added registration fee, but attendees at all levels are welcome to attend!
In addition to
NAVBO Travel and Outstanding Poster Awards,
The Microcirculatory Society and the
French Society of Angiogenesis are sponsoring travel awards and
ACS Pharmacology and Translational Science is supporting two poster awards.
Click here for more info.
Plus! Nano-Talks, Poster Sessions, a Poster Competition,
Exhibits, a Welcome Reception and a 25th Anniversary Celebration!
|
|
Meet One of Our New President Elect
|
Masanori Aikawa, M.D., Ph.D.
Dr. Aikawa is an Associate Professor at Harvard Medical School (HMS). At Brigham and Women's Hospital (BWH), he is the Yoshihiro Miwa Associate Chair and Founding Director of the Center for Interdisciplinary Cardiovascular Sciences (CICS) and one of the principal Investigators at the Center for Excellence in Vascular Biology. His laboratories explore new signaling mechanisms for macrophage activation. A series of his studies have demonstrated the pro-inflammatory role of Dll4-Notch signaling in vascular and metabolic diseases. More recently, Dr. Aikawa's systems approach to discovery of therapeutic targets for cardiovascular diseases has used innovative technologies including multi-omics, original bioinformatics programs, network analyses, and artificial intelligence.
Dr. Aikawa received his M.D. and Ph.D. degrees from Juntendo University in Tokyo, Japan. His initial research under the supervision of Dr. Ryozo Nagai at the University of Tokyo demonstrated the diversity of smooth muscle cell phenotype in developing and diseased arteries through the molecular cloning and characterization of human myosin heavy chain isoforms. As a Research Fellow in the laboratory of Dr. Peter Libby at BWH/HMS, he pioneered the theory of "plaque stabilization" by lipid lowering. As a faculty member of BWH/HMS, Dr. Aikawa provided the first in vivo evidence for the impact of MMP-collagenases on collagen in atherosclerosis and aneurysms. He published early reports of in vivo molecular imaging of atherosclerotic plaque macrophages. While continuously running his laboratory, sponsored by NIH, in the Center for Excellence in Vascular Biology, he launched CICS in 2009, as a new model of academia-industry partnership in drug discovery.
As a NAVBO member for 25 years, Dr. Aikawa has developed ideas for how we can work together to strengthen our organization and take it to the next level. He believes that we must continue to strive for diversity and support careers of women scientists. He is determined to find ways for increasing support for young investigators under the current funding climate. The speed of technological development is increasing exponentially. Dr. Aikawa is thus
passionate to bring more opportunities to NAVBO members to
learn new technologies, such as artificial intelligence, to speed up the translation of basic science into the clinic, and increase its success rates in clinical development. He believes that NAVBO has high potential to become an exciting interface between vascular biology and data science. As an internationally trained scientist, Dr. Aikawa is also enthusiastic to network with other communities, particularly scientific organizations in other countries.
For more information, please visit the websites of Dr. Aikawa's laboratories.
|
Seminal discovery in vascular development celebrated
NAVBO member David Hootnick has brought to our attention that 2019 marks the centenary of the publication of Harold Senior's landmark study, titled "The development of the arteries of the human lower extremity," in the American Journal of Anatomy. Senior, a faculty member in the Department of Anatomy at New York University, provided in this paper the structural basis for our understanding of mechanisms of developmental limb teratogenesis, including that associated with Thalidomide use during pregnancy. See Dr. Hootnick's detailed comments here.
If you would like to contribute an article for the NewsBEAT, send your piece to editor@navbo.org. Thank you!
|
NAVBO Continues to Bring You Exciting Webinars
Carlos Fernández-Hernando
Yale School of Medicine
Non-coding RNA regulation of lipid metabolism and atherosclerosis
September 12, 1:00pm EDT
Oklahoma Medical Research Foundation
Wnt/ß-catenin signaling, mechanotransduction and lymphatic vascular development
October 10, 1:00pm EDT
NAVBO Webinars are free to current NAVBO Members. Non-members can attend for $25 per webinar.
And don't forget you can watch archived webinars as well - go to
|
|
Don't Miss This!!! VB2019 Grants for Child Care
|
NAVBO announces grants to support child care expenses
The NAVBO Council voted to support grants for family members who may need additional support when attending a meeting. Go to
http://www.navbo.org/events/vb2019/childcare19/childcareinfo for more information and to apply.
The deadline for submission of an application has been extended to September 10, 2019.
Help support these grants by purchasing a Vascular Biology networking T-shirt or by giving a donation. NAVBO will support five grants at $400 each; all funds raised in this manner, even if above $2,000, will support these grants. Thank you for your support.
|
|
Promote Your Presentation on the Web Site
|
Current NAVBO Members Can List Their Upcoming Presentations (Oral or Poster) on our Web Site
Keep members, and all who visit our web site, aware of presentations by NAVBO members. If you are attending the meeting, be sure to attend your NAVBO colleague's presentation. If you are also presenting at that meeting, you can attend each other's presentations and offer mutual support! It can also help make you aware when a colleague is in your town so you reach out and arrange an in-person chat. And finally, this listing can also keep you abreast of other relevant meetings and conferences.
There is a form at the bottom of the page for you to add your presentation.
|
Civic Engagement Supported by Research!America
Research!America is announcing a
request for proposals from graduate student- and postdoc-led science policy groups for the alliance's civic engagement initiative. Started in 2018, the Civic Engagement Microgrant Program supports activities developed by students to connect directly with public officials and community leaders regarding the importance of scientific discovery and research.
Research!America, supported in part by a grant from the Rita Allen Foundation, is funding graduate student groups' nonpartisan activities of their design focusing on civic engagement and elevating the importance of scientific research, innovation and public health. These programs encourage dialogue between young scientists and local leaders about the roles science and research play in issues important to their communities. Groups are also encouraged to expand their efforts through partnerships with social science and communications students as part of the new Science Meets Science Microgrant Program.
Applications are due September 20, 2019
2019 Sartorius & Science Prize for Regenerative Medicine and Cell Therapy
Are you a representative of the upcoming generation of thought leaders in your field? Then go ahead and use this exciting opportunity to introduce yourself and your pioneering research to the world! We at Sartorius and Science look forward to receiving your application for the 2019 Sartorius &
Science Prize for Regenerative Medicine and Cell Therapy.
This annual prize is geared towards researchers focused on basic or translational research that advances regenerative medicine and cell therapy. Established in 2017, it is awarded for outstanding research performed by the applicant and as a mutual endeavor to raise awareness in the field. The prize is US$ 25,000, publication of your essay in
Science, publication in print of the Grand Prize essay and those of up to three runners-up on
Science Online, 5-year AAAS membership and online subscription to
Science and other perks and benefits from the sponsoring company, Sartorius
|
|
Call for Papers - Single-Cell Anaylysis
|
A Frontiers Research Topic initiated by NAVBO
Recent advances in analyzing tissues and organs at the single cell (SC) level are revolutionizing our understanding of organ development, biology, and disease. Previously, the genetic composition or transcriptional profiles of cells was based on sequencing DNA or RNA from a large number of cells, but this approach loses information on the heterogeneity of individual cells. Sequencing DNA and RNA from individual cells preserves heterogeneity, and technological advances have made these techniques highly accessible.
A recent analysis - available
here - of the SC extramural research funded by the NIH, either through NIH-initiated programs focused on SC or initiated by extramural investigators, revealed the paucity of such analyses related to vascular cells compared to a variety of other cells and tissues. This Research Topic is seeking to galvanize interest in SC applications related to the field of vascular cell biology and highlight original research related to SC analyses of vascular related cells, under normal or diseased conditions. We seek to understand the specific challenges associated with studying vascular cells, and how advances in SC approaches could benefit vascular fields. Submissions are due September 30, 2019.
More information can be found here on the Frontiers web site.
|
Welcome to our New Members:
Zahra Alvandi, Boston Children's Hospital
Emily Bramel, Johns Hopkins University School of Medicine
Hannah Cebull, Purdue University
Andrew Chang, Gladstone Institutes
Tyler Creamer, Johns Hopkins University
Tala Curry, Midwestern University
Wen Ding, Yale University
Raul Estrada, Alkahest
Xidi Feng, Saban Research Institute, Children's Hospital Los Angeles
Caitlin Francis, University of Denver
Amy Gardiner, University of New Mexico
Suman Gurung, Cincinnati Children's Hospital
Rebecca Harper, Stanford University
Kyuho Jeong, University of South Alabama
Karina Kinghorn, UNC Chapel Hill
Molly Kulikauskas, University of North Carolina Chapel Hill
Ziqing Liu, UNC-CH
Marcy Martin, Stanford University
Saejeong Park, Yale University
Natalija Popovic, Universite de Montreal
AnnJosette Ramirez, Rutgers University
Sung Rhee, University of Arkansas for Medical Sciences
Muzna Saqib, Johns Hopkins University
Sonali Shaligram, University of California, San Francisco
Alexandra Socovich, University of Illinois at Chicago
Noeline Subramaniam, University of Toronto
Natalie Tanke, The University of North Carolina at Chapel Hill
Shelby Thomas, Nationwide Children's Hospital
Dongdong Wang, LSU Health Sciences Center-Shreveport
Laureline Wetterwald, UNIL, CHUV
Zoë C. Wong, NHLBI
Shaka X, University of North Carolina at Chapel Hill
Shuai Yuan, University of Pittsburgh
Georgia Zarkada, Yale University
Ting Zhou, University of Wisconsin-Madison
|
|
Recent Publications by NAVBO Members
|
| Regulation of CCL2 expression in human vascular endothelial cells by a neighboring divergently transcribed long noncoding RNA
PNAS
Atherosclerosis is a chronic inflammatory disease that is driven, in part, by activation of vascular endothelial cells (ECs). In response to inflammatory stimuli, the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathway orchestrates the expression of a network of EC genes that contribute to monocyte recruitment and diapedesis across the endothelium. Read more Single-Cell Analysis of the Normal Mouse Aorta Reveals Functionally Distinct Endothelial Cell Populations
Circulation
BACKGROUND: The cells that form the arterial wall contribute to multiple vascular diseases. The extent of cellular heterogeneity within these populations has not been fully characterized. Recent advances in single-cell RNA-sequencing make it possible to identify and characterize cellular subpopulations. Read more |
|
Call for Papers on Regulation of Coronary Blood Flow
Consulting Editors Johnathan Tune and Donal O'Leary, and Guest Editor Judy Muller-Delp, along with the editorial team of the American Journal of Physiology - Heart and Circulatory Physiology, invite submission of manuscripts on the
regulation of coronary blood flow in normal and ischemic states
. In particular, the editors are interested in submissions investigating novel paradigms of coronary control, as well as discussion of translational perspectives and identification of essential unanswered questions. Another invitation from AJP seeks contributions on
microbiota and cardiovascular disease
. Submission deadline for both calls is August 31, 2019.
Single-cell transcriptomics define endothelial differentiation hierarchy
Samuel Lukowski and colleagues at the Universities of Queensland and New South Wales in Australia recently have
published in Cell Reports
their findings on the transcriptional differentiation of aortic endothelial cells. By using single-cell RNA sequencing and computational trajectory analyses to discern lineage relationships, the authors describe the presence of
two transcriptionally distinct endothelial cell populations within the aorta-progenitors and differentiated cells-that differ notably in expression of metabolic and mitochondrial gene networks. Bulk RNA-seq results derived from analysis of normal and tumor-derived vasculature are consistent with this differentiation paradigm.
Side benefit of biologic anti-inflammatories on coronary inflammation in psoriasis
Biologic anti-inflammatories, such as anti-TNFalpha, anti-IL-12/23, or anti-IL-17, used in patients with moderate to severe psoriasis can also significantly reduce coronary inflammation. The reporting study, funded by NHLBI and published in JAMA Cardiology, employed a novel imaging biomarker, the perivascular fat attenuation index (FAI), to assess reduced inflammation. Chronic inflammatory diseases, including lupus and rheumatoid arthritis, are associated with increased the risk for heart attacks and strokes. The FAI, which reflects changes in the composition of perivascular fat that occur as a consequence of chronic coronary artery inflammation, may provide a new reference point for therapeutic decisions in individual patients.
|
|
Job Postings
|
|
Job Title
|
Company
|
Location
|
Post-doctoral position in Vascular Biology
|
|
Milano, Lombardy, Italy
|
|
|
Victor Chang Cardiac Research Institute
|
New South Wales, Australia
|
Assistant Adjunct Professor in Cerebrovascular Biology
|
University of California, San Francisco
|
San Francisco, CA
|
|
|
LSU Health Sciences Center - Shreveport
|
Shreveport, LA
|
Assistant/Associate Professor - Vascular Surgery
|
Stanford University
|
Stanford, CA
|
|
|
Northwestern University
|
Chicago, IL
|
Postdoctoral Fellowship in Vascular and Valvular Remodeling
|
|
Pittsburgh, PA
|
|
|
University of Maryland
|
Baltimore, MD
|
|
|
|
